Alpha Recommendation & Small Cap watch list: BUY Polynovo PNV:ASX
Date: 8/11/2024
*** GENERAL AVICE ONLY***
Polynovo Limited (PNV) is involved in the development of innovative medical devices for a number of medical applications, utilising the patented bioabsorbable polymer technology NovoSorb. The Company can manufacture NovoSorb polymer devices with the ability to elute drugs, antimicrobials as well as be expressed in a variety of physical formats including, Films, foam, Coatings/sprays, Fibers, Plastic structures, Biologic carrier.
Rationale:
Polynovo offers investors exposure to a high-growth medical technology company addressing critical needs in wound care. With multiple growth levers, a clear path to profitability, and an experienced management team, we see significant upside potential in the shares from current levels. The company’s focus on innovation and improving patient outcomes positions it well to capture an increasing share of the large and growing advanced wound care market.
Trade Strategy: Buy Polynovo (PNV)
ALPHA
Entry: Buy up to $2.15
TARGET $2.75
Stop: 16% trailing stop loss
Small Cap Watchlist
Buy zone $2.15-$1.70
Long-term hold
Disclaimer: The recommendation given is general advice only. It does not take into account your personal objectives, financial situation, or specific needs. This information should not be your sole resource when making such decisions. We strongly recommend you to seek the advice of financial, taxation, and legal professionals before finalising any investment decisions.